Latest news
NKTR Nov 2026 75.000 call (NKTR261120C00075000) interactive stock chart - Yahoo Finance AustraliaYahoo Finance Australia · Fri, 07 Aug 2026 10:51:37 GMTCCORF Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Maintains Target Price $153 - MoomooMoomoo · Thu, 06 Aug 2026 11:31:00 GMTNKTR Q2'26 Earnings: revenue estimate is 10.42M USD - TradingViewTradingView · Thu, 06 Aug 2026 11:00:06 GMTNKTR Stock Soars After Nektar Reports Positive Atopic Dermatitis Trial Results - StocktwitsStocktwits · Wed, 05 Aug 2026 21:18:48 GMTBronstein, Gewirtz & Grossman, LLC Encourages Nektar Therapeutics - The National Law ReviewThe National Law Review · Wed, 05 Aug 2026 04:36:16 GMTNKTR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law ReviewThe National Law Review · Tue, 04 Aug 2026 13:23:12 GMTIs Global Phase 3 ZENITH AD Rezpegaldesleukin Program Altering The Investment Case For Nektar Therapeutics (NKTR)? - simplywall.stsimplywall.st · Mon, 03 Aug 2026 22:18:15 GMTNKTR Aug 2026 46.000 call (NKTR260821C00046000) stock price, news, quote and history - Yahoo Finance UKYahoo Finance UK · Mon, 03 Aug 2026 12:55:15 GMT